Skip to main content
OpenTrials
Completed

NCT Number: NCT06582030

Stop Addiction Stigma

This clinical trial evaluates the impact of a Stop Addiction Stigma (SAS) training workshop with a short description of the conditions related to addiction (vignettes) on stigmatizing attitudes toward individuals with substance abuse disorders. Reviews have shown that patients with substance abuse disorders have experienced negative attitudes from their health care providers. Negative attitudes may lead to less involvement from the provider and the patient and may lead to less effective care. Using case vignettes with a SAS workshop may be an effective method to help people learn about addiction, reduce the stigma toward addiction and improve the quality of health care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

About this study

PRIMARY OBJECTIVE:

I. To describe the impact of SAS training on participants' responses to people with a substance impairment.

SECONDARY OBJECTIVES:

I. To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel.

II. To explore the maintainability of responses over time. III. To explore relationships between language and stigmatizing attitudes.

OUTLINE: Participants are randomized to 1 of 6 group case vignettes.

GROUP A (CHRONICALLY RELAPSING BRAIN DISEASE): Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study.

GROUP B (BRAIN DISEASE): Participants view the brain disease vignette and attend a SAS workshop on study.

GROUP C (DISEASE): Participants view the disease vignette and attend a SAS workshop on study.

GROUP D (ILLNESS): Participants view the illness vignette and attend a SAS workshop on study.

GROUP E (DISORDER): Participants view the disorder vignette and attend a SAS workshop on study.

GROUP F (PROBLEM): Participants view the problem vignette and attend a SAS workshop on study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Employee of Ohio State University Wexner Medical Center (OSUWMC)
  • Age ≥ 18 years
  • Participants must be able to read and comprehend survey items

Treatment and study plan

Assessment

Behavioral

Ancillary studies

Other names: Assess, Study Assessment, Study Observation

Educational Activity

Other

View the chronically relapsing brain disease vignette

Training

Other

Attend a SAS workshop

Other names: Training Programs

Primary outcomes

  1. Stigmatizing attitudes

    Time frame: Before, immediately after and 8 weeks after the session

    Stigmatizing attitudes will be measured with the Stigma and Attribution Assessment. The assessment score will be compared both between and within participants for each case vignette. Results will be reported with descriptive statistics, including means and standard deviations or medians and first-third quartiles for continuous variables, and frequencies and percentages for discrete variables.The linear mixed effect model will be used to study the repeated stigma and attribution measures over time (pre-workshop, immediately post-workshop, and 8 weeks post-workshop) within 6 vignettes as well as the effects between the vignettes, while controlling for the potential confounding factors (e.g., sex).

Secondary outcomes

  1. Attendance rate

    Time frame: At 90 minute session.

    The proportion of participants attending the workshop will be summarized with 95% confidence interval.

  2. Response to post-workshop evaluations

    Time frame: Before, immediately following and 8 weeks after the session.

    The proportion of participants who respond to the post-workshop evaluations will be summarized with 95% confidence interval.

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

Stop Addiction Stigma Training Workshop With Case Vignettes to Decrease Stigmatizing Attitudes Toward People With Substance Abuse Disorders

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Sep 3, 2024
Registry last updated
Sep 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.